iShares U.S. Pharmaceuticals ETF
1. Exposure to U.S. companies that manufacture prescription or over-the-counter drugs or vaccines
2. Targeted access to domestic pharmaceutical stocks
3. Use to express a sector view
INVESTMENT OBJECTIVEThe iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.
Past distributions are not indicative of future distributions.
as of 26-Mar-2015
|Ticker||Name||Weight (%)||Sector||Market Value||Shares||Price||Exchange||Notional Value|
|JNJ||JOHNSON & JOHNSON||9.56||Health Care||$109,639,881||1,094,866||100.14||New York Stock Exchange Inc.||109,639,881.24|
|PFE||PFIZER INC||8.53||Health Care||$97,845,513||2,864,330||34.16||New York Stock Exchange Inc.||97,845,512.80|
|MRK||MERCK & CO INC||7.80||Health Care||$89,419,565||1,552,423||57.60||New York Stock Exchange Inc.||89,419,564.80|
|ACT||ACTAVIS PLC||6.86||Health Care||$78,676,460||261,106||301.32||New York Stock Exchange Inc.||78,676,459.92|
|BMY||BRISTOL MYERS SQUIBB||6.49||Health Care||$74,467,705||1,145,657||65.00||New York Stock Exchange Inc.||74,467,705.00|
|LLY||ELI LILLY||5.81||Health Care||$66,609,346||906,990||73.44||New York Stock Exchange Inc.||66,609,345.60|
|MYL||MYLAN NV||3.68||Health Care||$42,271,466||683,120||61.88||NASDAQ||42,271,465.60|
|PRGO||PERRIGO PLC||3.63||Health Care||$41,587,749||253,090||164.32||New York Stock Exchange Inc.||41,587,748.80|
|ZTS||ZOETIS INC CLASS A||3.59||Health Care||$41,150,823||892,449||46.11||New York Stock Exchange Inc.||41,150,823.39|
|MNK||MALLINCKRODT PLC||3.12||Health Care||$35,818,266||282,523||126.78||New York Stock Exchange Inc.||35,818,265.94|
|Ticker||ISIN||SEDOL||Name||Weight (%)||Asset Class||Sector||Market Value||Shares||Price||Exchange||Notional Value|
% of Market Value
Cash and/or Derivatives